Frontier Biopharma Limited NOTTINGHAM


Frontier Biopharma Limited is a private limited company located at Cawley House, 149-155 Canal Street, Nottingham NG1 7HR. Incorporated on 2021-01-20, this 3-year-old company is run by 4 directors.
Director Steven K., appointed on 02 February 2021. Director Marvin S., appointed on 02 February 2021. Director Kiren N., appointed on 20 January 2021.
The company is officially classified as "activities of production holding companies" (SIC: 64202). According to Companies House information there was a change of name on 2023-09-07 and their previous name was Drina Holdings Limited.
The latest confirmation statement was sent on 2023-01-19 and the due date for the subsequent filing is 2024-02-02. Moreover, the statutory accounts were filed on 31 January 2022 and the next filing should be sent on 02 January 2024.

Frontier Biopharma Limited Address / Contact

Office Address Cawley House
Office Address2 149-155 Canal Street
Town Nottingham
Post code NG1 7HR
Country of origin United Kingdom

Company Information / Profile

Registration Number 13146422
Date of Incorporation Wed, 20th Jan 2021
Industry Activities of production holding companies
End of financial Year 31st December
Company age 3 years old
Account next due date Tue, 2nd Jan 2024 (86 days after)
Account last made up date Mon, 31st Jan 2022
Next confirmation statement due date Fri, 2nd Feb 2024 (2024-02-02)
Last confirmation statement dated Thu, 19th Jan 2023

Company staff

Steven K.

Position: Director

Appointed: 02 February 2021

Marvin S.

Position: Director

Appointed: 02 February 2021

Kiren N.

Position: Director

Appointed: 20 January 2021

Mehmet S.

Position: Director

Appointed: 20 January 2021

People with significant control

The list of PSCs who own or have control over the company is made up of 3 names. As we found, there is Frontier Pharma Limited from London, United Kingdom. This PSC is categorised as "a limited company", has 25-50% voting rights and has 25-50% shares. This PSC has 25-50% voting rights and has 25-50% shares. The second entity in the PSC register is Joseph E. This PSC owns 50,01-75% shares. Then there is Kiren N., who also fulfils the Companies House criteria to be listed as a person with significant control. This PSC owns 75,01-100% shares and has 75,01-100% voting rights.

Frontier Pharma Limited

Kemp House 160 City Road, London, EC1V 2NX, United Kingdom

Legal authority Companies Act
Legal form Limited Company
Country registered England And Wales
Place registered England
Registration number 10130529
Notified on 2 February 2021
Nature of control: 25-50% voting rights
25-50% shares

Joseph E.

Notified on 18 March 2021
Ceased on 5 March 2024
Nature of control: 50,01-75% shares

Kiren N.

Notified on 20 January 2021
Ceased on 5 March 2024
Nature of control: 75,01-100% shares
75,01-100% voting rights

Company previous names

Drina Holdings September 7, 2023

Annual reports financial information

Profit & Loss
Accounts Information Date 2022-01-31
Balance Sheet
Net Assets Liabilities1 731 526
Other
Creditors3 823 126
Fixed Assets5 554 652
Total Assets Less Current Liabilities5 554 652

Company filings

Filing category
Accounts Address Capital Change of name Confirmation statement Incorporation Officers Persons with significant control Resolution
Address change date: Tue, 23rd Jan 2024. New Address: C/O Flb Accountants Llp 1010 Eskdale Road Winnersh Triangle Wokingham RG41 5TS. Previous address: Cawley House 149-155 Canal Street Nottingham Nottinghamshire NG1 7HR England
filed on: 23rd, January 2024
Free Download (1 page)

Company search